Sorry, I don't understand your search. ×

Cite

111 In-pentetreotide SPECT CT Value in Follow-up of Patients with Neuro-Endocrine Tumors.

MLA

Al-Suqri, Badriya. “111 In-Pentetreotide SPECT CT Value in Follow-up of Patients with Neuro-Endocrine Tumors.” Oman Medical Journal, vol. 29, no. 5, Sept. 2014, pp. 365–67. EBSCOhost, https://doi.org/10.5001/omj.2014.95.



APA

Al-Suqri, B. (2014). 111 In-pentetreotide SPECT CT Value in Follow-up of Patients with Neuro-Endocrine Tumors. Oman Medical Journal, 29(5), 365–367. https://doi.org/10.5001/omj.2014.95



Chicago

Al-Suqri, Badriya. 2014. “111 In-Pentetreotide SPECT CT Value in Follow-up of Patients with Neuro-Endocrine Tumors.” Oman Medical Journal 29 (5): 365–67. doi:10.5001/omj.2014.95.